Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

PURPOSE: The 21-gene OncotypeDX recurrence score (RS) assay quantifies the risk of distant recurrence in tamoxifen-treated patients with node-negative, estrogen receptor (ER)–positive breast cancer. We investigated the association between RS and risk for locoregional recurrence (LRR) in patients wit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mamounas, Eleftherios P., Tang, Gong, Fisher, Bernard, Paik, Soonmyung, Shak, Steven, Costantino, Joseph P., Watson, Drew, Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849763/
https://ncbi.nlm.nih.gov/pubmed/20065188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.7610
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares